Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 14, 2020
Letter to the editor regarding Gholamzad et al., "A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future"
Simon Faissner
CNS Drugs
|
May 26, 2018
Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner, Ralf Gold
Therapeutic Advances in Neurological Disorders
|
October 11, 2019
Progressive multiple sclerosis: latest therapeutic developments and future directions
Simon Faissner, Ralf Gold
CNS Drugs
|
July 22, 2022
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Simon Faissner, Ralf Gold
Fortschritte Der Neurologie-Psychiatrie
|
November 30, 2019
[New therapeutic approaches in progressive multiple sclerosis]
Simon Faissner, Ralf Gold
Cold Spring Harbor Perspectives in Medicine
|
March 4, 2018
Oral Therapies for Multiple Sclerosis
Simon Faissner, Ralf Gold
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2026
Beyond antibodies in GAD65 autoimmunity: Reframing pathogenesis through intrathecal B-T cell cross-talk
Simon Faissner, Ralf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2018
Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'
Simon Faissner, Ralf Gold
CNS Drugs
|
March 31, 2018
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner, Ralf Gold
Brain Sciences
|
June 2, 2021
Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years
Jannis Achenbach, Simon Faissner, Carsten Saft
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
January 14, 2020
Letter to the editor regarding Gholamzad et al., "A comprehensive review on the treatment approaches of multiple sclerosis: currently and in the future"
Simon Faissner
CNS Drugs
|
May 26, 2018
Correction to: Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner, Ralf Gold
Therapeutic Advances in Neurological Disorders
|
October 11, 2019
Progressive multiple sclerosis: latest therapeutic developments and future directions
Simon Faissner, Ralf Gold
CNS Drugs
|
July 22, 2022
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Simon Faissner, Ralf Gold
Fortschritte Der Neurologie-Psychiatrie
|
November 30, 2019
[New therapeutic approaches in progressive multiple sclerosis]
Simon Faissner, Ralf Gold
Cold Spring Harbor Perspectives in Medicine
|
March 4, 2018
Oral Therapies for Multiple Sclerosis
Simon Faissner, Ralf Gold
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2026
Beyond antibodies in GAD65 autoimmunity: Reframing pathogenesis through intrathecal B-T cell cross-talk
Simon Faissner, Ralf Gold
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2018
Clinical commentary on 'Severe hypertriglyceridemia associated with teriflunomide in a patient with multiple sclerosis'
Simon Faissner, Ralf Gold
CNS Drugs
|
March 31, 2018
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner, Ralf Gold
Brain Sciences
|
June 2, 2021
Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years
Jannis Achenbach, Simon Faissner, Carsten Saft
Page
of 9